Ythdf3-KO Mouse
一般名
Ythdf3-KO
製品ID
S-KO-06231
背景情報
C57BL/6NCya
系統ID
KOCMP-229096-Ythdf3-B6N-VA
状況
このマウス系統を論文で使用する場合は、「Ythdf3-KO Mouse（カタログ番号S-KO-06231）はサイアジェンから購入しました。」と引用してください。
製品タイプ
年齢
遺伝子型
性別
数量
標準的な配送方法では、少なくとも3匹のヘテロ接合体キャリアを保証しています。ホモ接合体キャリアや指定された性別の個体の繁殖サービスも利用可能です。
基本情報
系統名
Ythdf3-KO
系統ID
KOCMP-229096-Ythdf3-B6N-VA
遺伝子名
製品ID
S-KO-06231
遺伝子別名
9130022A11Rik
遺伝子別名
C57BL/6NCya
NCBI ID
修正
Conventional knockout
染色体
Chr 3
表現型
アプリケーション
--
さらに
系統詳細
EnsemblトランスクリプトID
ENSMUST00000108346
NCBIトランスクリプトID
NM_172677
ターゲット領域
Exon 3
有効領域の大きさ
~1.4 kb
遺伝子研究の概要
Ythdf3, an N6-methyladenosine (m6A) reader protein, is crucial in regulating the metabolism of m6A-modified mRNAs in the cytoplasm. It is involved in various biological processes such as translation, mRNA decay, and autophagy, and is associated with multiple disease-related pathways, especially cancer-related ones. Genetic models, like gene-knockout (KO) mouse models, can be valuable for further exploring its functions [4].
In breast cancer, Ythdf3 overexpression correlates with brain metastases. It promotes cancer cell interactions with brain-related cells, blood-brain barrier extravasation, angiogenesis, etc., by enhancing the translation of m6A-enriched transcripts for genes like ST6GALNAC5, GJA1, and EGFR [1]. In pancreatic cancer, ZDHHC20-mediated S-palmitoylation of Ythdf3 stabilizes MYC mRNA to promote cancer progression. Inhibition of Ythdf3 palmitoylation downregulates MYC expression and suppresses the progression of KRAS mutant pancreatic cancer [2]. For autophagy, Ythdf3 is essential for autophagy induction. It promotes autophagy by recognizing m6A modification sites around the stop codon of FOXO3 mRNA and recruiting translation-related factors to up-regulate FOXO3 translation [3,7]. In liver fibrosis, Ythdf3-mediated PRDX3 translation alleviates liver fibrosis [5]. In glioblastoma, Ythdf3 modulates the EGFR/ATK/ERK/p21 signaling axis to promote cancer progression and osimertinib resistance [6]. In melanoma, Ythdf3 regulates metastasis via its target LOXL3 [8]. In castration-resistant prostate cancer, Ythdf3 regulates the degradation and stability of m6A-enriched transcripts to facilitate cancer progression, and melatonin can inhibit Ythdf3-related activities [9].
In conclusion, Ythdf3 plays essential roles in multiple biological processes, especially in cancer-related events, as revealed through various functional studies. Model-based research, such as KO/CKO mouse models (although not explicitly detailed in all references), could potentially further clarify its functions in these specific disease areas, providing insights for targeted therapeutic strategies.
References:
1. Chang, Guoqiang, Shi, Lei, Ye, Youqiong, He, Chuan, Huang, Suyun. 2020. YTHDF3 Induces the Translation of m6A-Enriched Gene Transcripts to Promote Breast Cancer Brain Metastasis. In Cancer cell, 38, 857-871.e7. doi:10.1016/j.ccell.2020.10.004. https://pubmed.ncbi.nlm.nih.gov/33125861/
2. Zhang, Huan, Sun, Yan, Wang, Zhaokai, Jiang, Ke, Jin, Xin. 2024. ZDHHC20-mediated S-palmitoylation of YTHDF3 stabilizes MYC mRNA to promote pancreatic cancer progression. In Nature communications, 15, 4642. doi:10.1038/s41467-024-49105-3. https://pubmed.ncbi.nlm.nih.gov/38821916/
3. Hao, WeiChao, Dian, MeiJuan, Zhou, Ying, Sun, Yan, Xiao, Dong. 2022. Autophagy induction promoted by m6A reader YTHDF3 through translation upregulation of FOXO3 mRNA. In Nature communications, 13, 5845. doi:10.1038/s41467-022-32963-0. https://pubmed.ncbi.nlm.nih.gov/36195598/
4. Shi, Hailing, Wang, Xiao, Lu, Zhike, Liu, Chang, He, Chuan. 2017. YTHDF3 facilitates translation and decay of N6-methyladenosine-modified RNA. In Cell research, 27, 315-328. doi:10.1038/cr.2017.15. https://pubmed.ncbi.nlm.nih.gov/28106072/
5. Sun, Ruimin, Tian, Xinyao, Li, Yang, Zheng, Shusen, Yao, Jihong. 2022. The m6A reader YTHDF3-mediated PRDX3 translation alleviates liver fibrosis. In Redox biology, 54, 102378. doi:10.1016/j.redox.2022.102378. https://pubmed.ncbi.nlm.nih.gov/35779442/
6. Lee, Hsun-Hua, Hsieh, Ching-Chuan, Chang, Cheng-Chih, Liao, Wan-Ting, Chi, Hsiang-Cheng. . YTHDF3 Modulates EGFR/ATK/ERK/p21 Signaling Axis to Promote Cancer Progression and Osimertinib Resistance of Glioblastoma Cells. In Anticancer research, 43, 5485-5498. doi:10.21873/anticanres.16751. https://pubmed.ncbi.nlm.nih.gov/38030188/
7. Hao, WeiChao, Dian, MeiJuan, Wang, JiaHong, Sun, Yan, Xiao, Dong. 2022. Epitranscriptomic turbo for autophagy boost: m6A reader YTHDF3. In Autophagy, 19, 1882-1884. doi:10.1080/15548627.2022.2146890. https://pubmed.ncbi.nlm.nih.gov/36374269/
8. Shi, Hao-Ze, Xiong, Jing-Shu, Gan, Lu, Sun, Jian-Fang, Chen, Hao. . N6-methyladenosine reader YTHDF3 regulates melanoma metastasis via its 'executor'LOXL3. In Clinical and translational medicine, 12, e1075. doi:10.1002/ctm2.1075. https://pubmed.ncbi.nlm.nih.gov/36324258/
9. Duan, Juanjuan, Fan, Daogui, Chen, Pingping, Yu, Wenfeng, Zhang, Qifang. . YTHDF3 Regulates the Degradation and Stability of m6A-Enriched Transcripts to Facilitate the Progression of Castration-Resistant Prostate Cancer. In Journal of pineal research, 76, e13003. doi:10.1111/jpi.13003. https://pubmed.ncbi.nlm.nih.gov/39143673/
品質管理基準
精子検査
凍結前の精子濃度を測定し、精子の生存能力の判定します。
凍結後の精子では、各バッチから1本の凍結保存された精子を選び出し、体外受精に使用します。
環境基準:
SPF対応地域:
グローバル由来:
Cyagenお問い合わせ
カスタムの動物モデルに関するご相談は、下記のフォームにご記入いただき、ご連絡いただくか見積もりをご依頼ください。
Cyagenはお客様のプライバシーを大変重視しています。当社の最新の製品や情報をお届けしたいと思っています。お客様の設定をご確認ください。
これらの配信はいつでも解除できます。配信停止方法およびデータ保護の詳細は プライバシーポリシー をご確認ください。
以下のボタンをクリックすることで、このフォームにご入力いただいた個人情報をCyagenが保存・処理し、ご要望のコンテンツを提供することに同意されたことになります。